NCT03562897 2022-07-06Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial CancerCatalysis SLPhase 2 Completed40 enrolled
NCT03403777 2019-03-05Avelumab in Refractory Testicular Germ Cell Cancer.National Cancer Institute, SlovakiaPhase 2 Completed8 enrolled